WALL, NJ--(Marketwired - July 22, 2014) - BIO-key International, Inc. (OTCQB: BKYI), a leader in fingerprint biometric identification technologies, cloud-based mobile credentialing and identity verification solutions, today reported the company is entering into a strategic relationship with Experian Public Sector.
BIO-key's fingerprint-based biometric identification technology along with Experian's existing suite of identity verification products will greatly expand access to identity proofing for those authentication transactions requiring the highest level of assurance.
"By adding BIO-key's world class technology to our industry-leading suite of fraud solutions which includes Precise ID, Experian customers will be able to positively ID an enrolled individual during face-to-face encounters, online via the internet or by mobile devices when speed and efficiency are paramount. The overall identification process which operates seamlessly across dozens of heterogeneous, low-cost fingerprint scanners, will add an additional level of scrutiny for transactions that require compliance with NIST 800-63 guidelines at level of assurance 4," said Philippe de Raet, Vice President of Business Development and Strategic Alliances for Experian Public Sector.
"We believe that the growing interest in mobile fingerprint authentication positions BIO-key and Experian to capitalize on the strengths of each in adding the key element of trust to any authentication process requiring the strongest level of assurance," stated Mike DePasquale, BIO-key Chairman and CEO. "The opportunity for relying parties to leverage Experian and a cloud based biometric ID verification prior to enrolling an individual in a biometric ID process of their own establishes an unprecedented root of trust to all subsequent activity."
BIO-key technology is positioned as an additive layer of authentication capability for Experian customers seeking to incorporate fingerprint biometric authentication. Together, we deliver streamlined multi-factor ID proofing services and fraud prevention through the combined strength of the two market leaders. Target markets include fraud-rich environments such as Government, Healthcare and Banking and the joint offering will enhance the authentication process for benefits eligibility of constituents in markets calling for trustworthy ID with both an in-person and online touch point.
BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key's award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world's largest identification deployments to improve security, guarantee identity, and help reduce identity theft. BIO-key's technology is offered directly or by market leading partners around the world. (http://www.bio-key.com)
Experian is the leading global information services company, providing data and analytical tools to clients around the world. The Group helps businesses to manage credit risk, prevent fraud, target marketing offers and automate decision making. Experian also helps individuals to check their credit report and credit score, and protect against identity theft.
Experian plc is listed on the London Stock Exchange (EXPN) and is a constituent of the FTSE 100 index. Total revenue for the year ended March 31, 2014, was US$4.8 billion. Experian employs approximately 16,000 people in 39 countries and has its corporate headquarters in Dublin, Ireland, with operational headquarters in Nottingham, UK; California, US; and São Paulo, Brazil.
For more information, visit http://www.experianplc.com.
BIO-key Safe Harbor Statement
Certain statements contained in this press release are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, wider market acceptance of biometric technologies, our ability to raise additional financing, and our ability to attract and retain key personnel. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2013 and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company undertakes no obligation to disclose any revision to these forward-looking statements whether to reflect events or circumstances after the date hereof or otherwise.